Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Somatostatin may help protect hair follicles from immune attacks.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Pantethine may boost the immune system's ability to fight sarcoma.

Fetal skin has unique immune cells different from adult skin.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Dental pulp stem cells might not reliably become neurons.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

A stable sheep ovarian cell line was created for studying reproduction and hormones.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Most pediatric cancer patients in the study developed skin problems, often due to their cancer treatment.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Nanozymes show promise for effective and safe cancer treatment.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.